These novel treatments, Semaglutide , represent a significant advancement in managing type 2 diabetes and potentially related conditions . These drugs are categorized as GLP-1 hormone activators , signifying these substances to replicate the endogenous GLP-1 hormone , enhancing metabolic production and suppressing food intake. Despite Tirzepatid… Read More